Nihon Chouzai Co Ltd
TSE:3341
Nihon Chouzai Co Ltd
Cost of Revenue
Nihon Chouzai Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Nihon Chouzai Co Ltd
TSE:3341
|
Cost of Revenue
-¥278.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
Sundrug Co Ltd
TSE:9989
|
Cost of Revenue
-¥550B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Tsuruha Holdings Inc
TSE:3391
|
Cost of Revenue
-¥704.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Cost of Revenue
-¥840B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Cost of Revenue
-¥659.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Cost of Revenue
-¥721.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
See Also
What is Nihon Chouzai Co Ltd's Cost of Revenue?
Cost of Revenue
-278.8B
JPY
Based on the financial report for Dec 31, 2023, Nihon Chouzai Co Ltd's Cost of Revenue amounts to -278.8B JPY.
What is Nihon Chouzai Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Nihon Chouzai Co Ltd have been -7% over the past three years , -7% over the past five years , and -8% over the past ten years .